Cargando…

Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis

BACKGROUND: Identification of patients with oral dysplasia at high risk of cancer development and oral squamous cell carcinoma (OSCC) at increased risk of disease recurrence will enable rigorous personalized treatment. Regulated intramembranous proteolysis of Epithelial cell adhesion molecule (EpCAM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somasundaram, Raj Thani, Kaur, Jatinder, Leong, Iona, MacMillan, Christina, Witterick, Ian J., Walfish, Paul G., Ralhan, Ranju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947324/ https://www.ncbi.nlm.nih.gov/pubmed/27421772 http://dx.doi.org/10.1186/s12885-016-2507-7

Ejemplares similares

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
por: Kunavisarut, Tada, et al.
Publicado: (2012)

Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015)

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy
por: Fu, Guodong, et al.
Publicado: (2016)

An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma
por: He, Helen C.-H., et al.
Publicado: (2012)

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
por: Ralhan, Ranju, et al.
Publicado: (2010)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy
por: Srivastava, Gunjan, et al.
Publicado: (2015)

Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
por: Srivastava, Gunjan, et al.
Publicado: (2014)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients
por: Kumar, Manish, et al.
Publicado: (2015)

Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
por: Fu, Guodong, et al.
Publicado: (2017)

Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions
por: Hsieh, Anne M.-Y., et al.
Publicado: (2018)

Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression
por: Kaur, Jatinder, et al.
Publicado: (2013)

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
por: Chowdhury, Subrata, et al.
Publicado: (2016)

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
por: Chauhan, S S, et al.
Publicado: (2015)

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer
por: Kumar, Manish, et al.
Publicado: (2015)

Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients
por: Hasan, Md. Raghibul, et al.
Publicado: (2013)

Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens
por: Fu, Guodong, et al.
Publicado: (2021)

Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis
por: Hasan, Raghibul, et al.
Publicado: (2014)

Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
por: Assi, Jasmeet, et al.
Publicado: (2013)

Clinical significance of Phosphatidyl Inositol Synthase overexpression in oral cancer
por: Kaur, Jatinder, et al.
Publicado: (2010)

Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2010)

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules
por: Fu, Guodong, et al.
Publicado: (2023)

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
por: Matta, Ajay, et al.
Publicado: (2009)

Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model
por: Hasan, Raghibul, et al.
Publicado: (2022)

AV Nodal Reentrant Tachycardia Causing Inappropriate ICD Shocks In A Patient With Arrhythmogenic RV Dysplasia
por: Prasad, Subramanya, et al.
Publicado: (2009)

Soluble and Membranous Vascular Endothelial Growth Factor Receptor-2 in Pregnancies Complicated by Pre-Eclampsia
por: Tripathi, Richa, et al.
Publicado: (2009)

Subcutaneous ICD for more and transvenous ICD for few?!
por: Abdin, Amr, et al.
Publicado: (2022)

Over-expression of 14-3-3zeta is an early event in oral cancer
por: Matta, Ajay, et al.
Publicado: (2007)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

Traumatic experiences, ICD‐11 PTSD, ICD‐11 complex PTSD, and the overlap with ICD‐10 diagnoses
por: Møller, L., et al.
Publicado: (2020)

14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells
por: Macha, Muzafar A, et al.
Publicado: (2010)

Box full of tales: easy ways to share library resources through story boxes
por: MacMillan, Kathy
Publicado: (2016)

Astronomers no longer in the dark
por: MacMillan, L
Publicado: (2002)

Prostaglandin E2 facilitates subcellular translocation of the EP4 receptor in neuroectodermal NE-4C stem cells
por: Davidson, Jennilee M., et al.
Publicado: (2016)

Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
por: Prasad, Chandra P, et al.
Publicado: (2009)

Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins
por: Mirza, Sameer, et al.
Publicado: (2013)

Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2011)

Variability in clinical diagnoses during the ICD-8 and ICD-10 era
por: Nordgaard, Julie, et al.
Publicado: (2016)

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer
por: Su, Duntao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ltnkpmiib2jltku09ekfdp0gp